Invasive n (%) | Non-invasive n (%) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2011 | 2012 | 2013 | 2014 | 2015 | Total | 2011 | 2012 | 2013 | 2014 | 2015 | Total | |
No of isolates | 1 (0.2) | 10 (2.4) | 9 (2.1) | 4 (1) | 19 (4.5) | 43 (10.2) | 17 (4) | 48 (11.4) | 31 (7.4) | 67 (16) | 214 (51) | 377 (89.8) |
No of patients | 1 (0.3) | 10 (2.8) | 8 (2.2) | 4 (1.1) | 17 (4.8) | 40 (11.2) | 14 (3.9) | 40 (11.2) | 26 (7.3) | 57 (16) | 179 (50.3) | 316 (88.8) |
Age groups of patient | ||||||||||||
0–24 months | 0 (0) | 1 (0.3) | 1 (0.3) | 1 (0.3) | 4 (1.1) | 7 (2) | 1 (0.3) | 1 (0.3) | 1 (0.3) | 7 (2) | 24 (6.7) | 34 (9.6) |
25–59 months | 0 (0) | 0 (0) | 1 (0.3) | 0 (0) | 1 (0.3) | 2 (0.6) | 1 (0.3) | 1 (0.3) | 3 (0.8) | 0 (0) | 14 (3.9) | 19 (5.3) |
5–18 years | 1 (0.3) | 2 (0.6) | 1 (0.3) | 2 (0.6) | 3 (0.8) | 9 (2.5) | 9 (2.5) | 18 (5) | 12 (3.4) | 23 (6.5) | 67 (18.8) | 129 (36.2) |
19–65 years | 0 (0) | 4 (1.1) | 5 (1.4) | 1 (0.3) | 4 (1.1) | 14 (3.9) | 2 (0.6) | 16 (4.5) | 8 (2.2) | 23 (6.5) | 47 (13.2) | 96 (27) |
>65 years | 0 (0) | 3 (0.8) | 0 (0) | 0 (0) | 5 (1.4) | 8 (2.2) | 1 (0.3) | 4 (1.1) | 2 (0.6) | 4 (1.1) | 27 (7.6) | 38 (10.7) |
Comorbidities | ||||||||||||
No comorbidity | 0 (0) | 2 (0.6) | 5 (1.4) | 2 (0.6) | 7 (2) | 16 (4.5) | 4 (1.1) | 5 (1.4) | 5 (1.4) | 20 (5.6) | 60 (16.9) | 94 (26.4) |
Asthma | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0 ) | 0 (0) | 2 (0.6) | 7 (2) | 6 (1.7) | 10 (2.8) | 38 (10.6) | 63 (17.7) |
Bronchiectasis | 0 (0) | 1 (0.3) | 0 (0) | 0 (0) | 0 (0) | 1 (0.3) | 2 (0.6) | 8 (2.2) | 6 (1.7) | 5 (1.4) | 24 (6.7) | 45 (12.6) |
Malignancy | 0 (0) | 3 (0.8) | 1 (0.3) | 1 (0.3) | 2 (0.6) | 7 (2) | 0 (0) | 6 (1.7) | 2 (0.6) | 3 (0.8) | 10 (2.8) | 21 (5.9) |
Cystic fibrosis | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.3) | 3 (0.8) | 2 (0.6) | 3 (0.8) | 18 (5.1) | 27 (7.6) |
Immunodeficiencies | 0 (0) | 2 (0.6) | 0 (0) | 0 (0) | 0 (0) | 2 (0.6) | 0 (0) | 3 (0.8) | 4 (1.1) | 8 (2.2) | 7 (2) | 22 (6.2) |
Others | 1 (0.3) | 2 (0.6) | 2 (0.6) | 1 (0.3) | 8 (2.2) | 14 (3.9) | 5 (1.4) | 8 (2.2) | 1 (0.3) | 8 (2.2) | 22 (6.3) | 44 (12.4) |